Skip to main content
Premium Trial:

Request an Annual Quote

Whatman/Schleicher & Schuell and German Clinical Dx Lab to Market Protein Chip-Based Autoimmune Assay

NEW YORK, Aug. 9 (GenomeWeb News) - Whatman/Schleicher & Schuell and the Private Institute for Immunology and Molecular Genetics of Germany plan to market a diagnostic protein biochip for autoimmune diseases they have co-developed, Whatman said yesterday.

 

The chip, based on Whatman/Schleicher & Schuell's nitrocellulose-coated FAST slides, allows researchers to measure autoantibodies associated with collagenosis and vasculititis-related autoimmune diseases.

 

At the moment, the chip is being validated for compliance with CE guidelines for in vitro diagnostics. The companies plan to launch the diagnostic test at the end of the year.

The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more